Correlation Between AC Immune and Icosavax
Can any of the company-specific risk be diversified away by investing in both AC Immune and Icosavax at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AC Immune and Icosavax into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AC Immune and Icosavax, you can compare the effects of market volatilities on AC Immune and Icosavax and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AC Immune with a short position of Icosavax. Check out your portfolio center. Please also check ongoing floating volatility patterns of AC Immune and Icosavax.
Diversification Opportunities for AC Immune and Icosavax
Pay attention - limited upside
The 3 months correlation between ACIU and Icosavax is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding AC Immune and Icosavax in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Icosavax and AC Immune is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AC Immune are associated (or correlated) with Icosavax. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Icosavax has no effect on the direction of AC Immune i.e., AC Immune and Icosavax go up and down completely randomly.
Pair Corralation between AC Immune and Icosavax
Given the investment horizon of 90 days AC Immune is expected to generate 0.88 times more return on investment than Icosavax. However, AC Immune is 1.14 times less risky than Icosavax. It trades about 0.03 of its potential returns per unit of risk. Icosavax is currently generating about 0.0 per unit of risk. If you would invest 239.00 in AC Immune on November 2, 2024 and sell it today you would earn a total of 31.00 from holding AC Immune or generate 12.97% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 22.67% |
| Values | Daily Returns |
AC Immune vs. Icosavax
Performance |
| Timeline |
| AC Immune |
| Icosavax |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
AC Immune and Icosavax Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with AC Immune and Icosavax
The main advantage of trading using opposite AC Immune and Icosavax positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AC Immune position performs unexpectedly, Icosavax can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Icosavax will offset losses from the drop in Icosavax's long position.| AC Immune vs. Pmv Pharmaceuticals | AC Immune vs. MediciNova | AC Immune vs. Pharvaris BV | AC Immune vs. PepGen |
| Icosavax vs. Terns Pharmaceuticals | Icosavax vs. Amylyx Pharmaceuticals | Icosavax vs. Acumen Pharmaceuticals | Icosavax vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Other Complementary Tools
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |